Search Results
Sep 09, 2026, 16:53 ET Seismic Pharmaceuticals Announces the Enrollment of the First Patient in the Global Phase 3 Trial of Istaroxime in Cardiogenic Shock
an approved pharmacologic therapy specifically developed for this syndrome," said the study principal investigator Dr. Mandeep R. Mehra, MBBS, MSc, FRCP, The William Harvey Distinguished Chair in Advanced Cardiovascular Medicine, Mass General Brigham Heart & Vascular Institute, Professor of
More news about: Seismic Pharmaceuticals
Sep 09, 2026, 09:04 ET Onix Expands Its Trusted AI Platform With $5 Million USD Pre-Seed Round
Christian Drapeau, MSc;
More news about: Onix
Sep 08, 2026, 14:50 ET Norsemont to Participate at Precious Metals Summit Beaver Creek
neither Spark nor its principals held any direct or indirect interest in the securities of the Company.Qualified PersonDavid Flint, MSc, AIPG-CPG, and Chief Geologist of Norsemont Mining Inc.; a qualified person as defined in NI 43-101, has reviewed and approved the technical information
More news about: Norsemont Mining Inc
Sep 02, 2026, 08:30 ET New HCPCS Billing Code Enables Medicare Benefit Billing of Lasix® ONYU When Furnished Incident to a Physician's Service
self-administered course of diuretics could be one part of a solution to the bigger problem of ER boarding and waiting room medicine," said Sean Collins, MD, MSc, Professor of Emergency Medicine and Director of the Vanderbilt Coordinating Center, Vanderbilt Health, Nashville. "Avoiding an unnecessary admission
More news about: SQ Innovation
Sep 02, 2026, 07:00 ET Alteogen Enters Option and License Agreement with Novartis for Development and Commercialization of Hybrozyme™-Enabled Subcutaneous Products
8998E-mail: [email protected] Akolkar, MSc, MBABusiness Development DirectorPhone: +1 862 235 8516E-mail:
More news about: Alteogen Inc.
Sep 02, 2026, 07:00 ET Verdera Energy Announces Sale of Treeline Project, New Mexico
minerals produced from the Property which can be reduced to 1.0% by payment of C$400,000 to Verdera.Qualified PersonMark Pelizza, MSc, C.P.G, a Director and Qualified Person under NI 43-101, has reviewed and approved the technical disclosure in this news release.1.The
More news about: Verdera Energy Corp.
Sep 01, 2026, 16:15 ET MSC Income Fund Announces Completion of $150.0 Million Investment Grade Notes Offering
HOUSTON, Sept. 1, 2026 /PRNewswire/ -- MSC Income Fund, Inc. (NYSE: MSIF) ("MSC Income" or the "Fund") is pleased to announce the closing of a private notes offering totaling $150.0 million in aggregate principal amount (the
More news about: MSC Income Fund, Inc.
Aug 31, 2026, 19:28 ET AAN and AHS issue updated guideline on migraine prevention medications for adults
different ways, including newer classes of medications that have been released in the past several years," said guideline author Tamara Pringsheim, MD, MSc, of the University of Calgary in Alberta, Canada, and a Fellow of the American Academy of Neurology. "For people experiencing frequent migraine attacks
More news about: American Academy of Neurology
Aug 31, 2026, 11:00 ET American Board of Medical Specialties Research and Education Foundation Announces Recipients of 2026 - 2028 Research Grants
Medicine, Northwestern University - Harnessing EHR Data to Develop Low-touch Assessments of Bedside Clinical SkillsMartin Wegman, MD, PhD, MSc, FACEP, Head of Research, American College of Emergency Physicians - Practice‑Derived Knowledge Needs in Emergency Medicine: Comparing
More news about: American Board of Medical Specialties
Aug 31, 2026, 10:31 ET Musculoskeletal Pain Market Poised for Transformation During the Forecast Period (2026-2036) as Novel Therapies and Non-Opioid Approaches Reshape Treatment | DelveInsight
Forecasting & Analytics at DelveInsight, said that among emerging therapies, Rexlemestrocel-L is expected to have the highest uptake potential due to its MSC-based regenerative mechanism and ability to address the high unmet need in chronic low back pain. If clinical studies confirm durable pain relief and
More news about: DelveInsight Business Research, LLP
Aug 28, 2026, 08:46 ET AAPL Publishes New Book by Nationally Recognized Physician Leader Calling Women in Healthcare to Lead -- and Equipping Them to Succeed
recognized model for high-quality, cost-effective care for vulnerable populations — for 20 years before retiring in 2012.Karen B. DeSalvo, MD, MPH, MSc, Google Chief Health Officer (Retired), writes in the Foreword, "Anyone who is a gatekeeper of talent, resources, or policy has a role to play because
More news about: American Association for Physician Leadership (AAPL)
Aug 28, 2026, 08:36 ET Choose Health Launches Most Comprehensive At-Home Liver Function Test with 20+ Biomarkers and Clinical Risk Scores
Index, Hepatic Steatosis Index and AST:ALT ratio."These calculated scores are what actually matter clinically," said Dr. Alan Farrell, MB BCh BAO MSc, Chief Medical Officer at Choose Health and preventative medicine expert. "One elevated ALT reading doesn't say much. But when you combine multiple biomarkers
More news about: Choose Health
Aug 27, 2026, 08:30 ET Assessing the Use of Non-Human Primates in Translational Research Today, Upcoming Webinar Hosted by Xtalks
growing public and regulatory scrutiny.Join Gourav Roy-Choudhury, PhD, DABT, Senior Director, Toxicology, Franklin Biolabs; Thierry Decelle, DVM, MSc, DipVetLAS, Founder & CEO, DCL Solutions; and Andrea Varrone, MD, PhD, Professor of Molecular PET, Department of Clinical Neuroscience, Karolinska
More news about: Xtalks
Aug 26, 2026, 06:48 ET JinkoSolar Appoints New Chief Executive Officer
Mart (Group) Co., Ltd. from October 2018 to January 2021. Mr. Du holds a BSc degree in accounting and finance from the University of Bristol and an MSc degree in finance from Imperial College London, United Kingdom."We are pleased to welcome Mr. Du as our chief executive officer," commented Mr.
More news about: JinkoSolar Holding Co., Ltd.
Aug 24, 2026, 10:46 ET Vascular Innovation Takes Center Stage at The VEINS and VIVA 2026
Conditions (Diabetes Mellitus, CTO, Long Lesions, and/or Calcified Lesions) Treated With DES From the ELEGANCE RegistryEric A. Secemsky, MD, MSc9-Month Outcomes of the AGILITY Trial Iliac Cohort: A Prospective, Multicenter Study on Revello™, a Low-Profile Self-Expanding Covered StentSean
More news about: The VIVA Foundation
Aug 24, 2026, 09:10 ET New CU Anschutz Division of Transplant Medicine is First of Its Kind Nationally
specialists together around the patient rather than organizing them primarily by organ or traditional medical specialty," said Vineet Chopra, MBBS, MD, MSc, executive vice dean and chair of the CU Anschutz Department of Medicine in the CU Anschutz School of Medicine. Traditionally, transplant specialists
More news about: University of Colorado Anschutz
Aug 24, 2026, 08:15 ET BrainStorm Executive Leadership to Participate in DUPHAT 2026; Executive Chairman Peter J. Pitts Invited to Deliver Two Keynote Addresses and Moderate Panel Sessions
NurOwn®The NurOwn® technology platform (autologous MSC-NTF cells) represents a promising investigational therapeutic approach to targeting disease pathways important in neurodegenerative disorders. MSC-NTF cells are produced from autologous mesenchymal stem cells (MSCs) derived
More news about: BrainStorm Cell Therapeutics Inc.
Aug 20, 2026, 10:11 ET Dr. Stacy Sims Joins Livelong Media as Chief Science Advisor
NEW YORK, Aug. 20, 2026 /PRNewswire/ -- Livelong Media today announced that Dr. Stacy Sims MSc, PhD has joined the company as Chief Science Advisor, effective July 31, 2026. Sims, an exercise physiologist and nutrition scientist known for her research
More news about: Livelong Media
Aug 18, 2026, 07:00 ET Main Street Announces New Portfolio Investment
$500 million.Main Street, through its wholly-owned portfolio company MSC Adviser I, LLC ("MSC Adviser"), also maintains an asset management business through which it manages investments for external parties. MSC Adviser is registered as an investment adviser under the Investment Advisers Act
More news about: Main Street Capital Corporation
Aug 17, 2026, 10:00 ET Iorio Law PLLC Now Represents Investors Holding More Than $50 Million in Delaware Statutory Trust (DST) Investments, Including More Than $40 Million in Versity/Crew DSTs
Inc.; Dempsey Lord Smith, LLC; WealthForge Securities, LLC; AAG Capital, Inc.; Cabin Securities, Inc.; Aurora Securities, Inc.; Capulent LLC; and MSC-BD, LLC. The managing broker-dealer for particular Versity- or Crew-related offerings varied by offering and investment date; Emerson Equity LLC, WealthForge
More news about: Iorio Law PLLC
Aug 17, 2026, 08:30 ET A Practical Guide to Conducting In-Trial Patient Interviews, Upcoming Webinar Hosted by Xtalks
CLINIGMA®, Jens Harald Kongsø, MSc in Economics, Founder and CEO; Julie Perch, MA in Applied Cultural Analysis, Chief Operating Officer; and Linda Nelsen, MHS in Epidemiology, Scientific
More news about: Xtalks
Aug 14, 2026, 16:00 ET BrainStorm Cell Therapeutics Announces Second Quarter 2026 Financial Results and Provides Corporate Update
About NurOwn®The NurOwn® technology platform (autologous MSC-NTF cells) represents a promising investigational therapeutic approach to targeting disease pathways important in neurodegenerative disorders. MSC-NTF cells are produced from autologous, bone marrow-derived mesenchymal stem
More news about: BrainStorm Cell Therapeutics Inc.
Aug 13, 2026, 08:30 ET AI-Enabled Pharmacovigilance: Practical Strategies for Smarter Safety Operations, Upcoming Webinar Hosted by Xtalks
Allucent; Georgia Kolangi, MSc, Associate Director, Pharmacovigilance, Allucent; and Rosanna Eccel, Head of Global Pharmacovigilance, Nextrove, for the live webinar on Thursday, September
More news about: Xtalks
Aug 10, 2026, 16:30 ET CHS-Northwest celebrates DPT Class of 2029 at annual white coat ceremony
individuals toward health, movement, and a better quality of life."To conclude the white coat ceremony, CHS-Northwest Site Dean Jonathan Perry, MSc, PhD, encouraged the incoming physical therapy students to embrace every opportunity their education will offer. As they begin the next chapter of their
More news about: Western University of Health Sciences (WesternU)
Aug 10, 2026, 09:40 ET AQUAPASS Completes Enrollment in REFORM-HF Pivotal Trial, Results to Be Presented at Major Heart Failure Conference This Fall
https://clinicaltrials.gov/study/NCT06360380#contacts-and-locations "This is a major milestone for AQUAPASS and for the patients we aim to serve," said Noam Josephy, MD, MSc, MBA, Chief Executive Officer of AQUAPASS. "We're now focused on completing our data analysis, preparing for presentation and publication, and advancing
More news about: AQUAPASS, Inc.